• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内和开放腹主动脉瘤修复后的长期年龄分层生存。

Long-term age-stratified survival following endovascular and open abdominal aortic aneurysm repair.

机构信息

Department of Surgery, Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Vascular Surgery, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.

Department of Surgery, Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; Department of Vascular Surgery, Amsterdam University Medical Centers (Amsterdam UMC), VUMC, Amsterdam, the Netherlands.

出版信息

J Vasc Surg. 2022 Oct;76(4):899-907.e3. doi: 10.1016/j.jvs.2022.03.867. Epub 2022 Mar 31.

DOI:10.1016/j.jvs.2022.03.867
PMID:35367565
Abstract

OBJECTIVE

The long-term survival differences between endovascular repair (EVAR) and open repair for abdominal aortic aneurysms (AAAs) and specifically the impact of age on these differences remain a topic of debate. Therefore, we compared the long-term mortality between EVARand open abdominal aneurysm repair for patients of different ages.

METHODS

This was a retrospective cohort study of prospectively collected data from patients undergoing elective EVAR or open repair for infrarenal AAAs within the Vascular Quality Initiative multinational clinical registry (2003-2021). The primary outcome was long-term all-cause mortality comparing EVAR and open repair for patients aged less than 65 years, between 65 and 79 years, and those aged 80 and older. In addition, we investigated the interaction between repair modality and 10-year hazard of mortality for sex, aneurysm diameter, and several preoperative comorbid conditions within each age category. To account for the nonrandom assignment of treatment, we used propensity scores and inverse probability weighted Cox proportional hazard analysis.

RESULTS

We identified 48,074 patients undergoing elective infrarenal abdominal aneurysm repair (89% EVAR) within the study period, including 7940 patients aged less than 65, 29,555 aged between 65 and 79, and 10,579 aged 80 years or more. EVAR was associated with a higher propensity score-adjusted long-term hazard of mortality compared with open repair in the cohort aged less than 65 years (hazard ratio [HR], 1.39; 95% confidence interval [CI], 1.04-1.86; P = .026). The mortality was similar in the age cohort between 65 and 79 (HR, 0.94; 95% CI, 0.79-1.10; P = .43), whereas EVAR was associated with a lower hazard of mortality in the cohort aged 80 years or more (HR, 0.63; 95% CI, 0.46-0.86; P = .004). In patients aged less than 65 years, the hazard of mortality was higher with EVAR compared with open repair in those with female sex (HR, 4.40; 95% CI, 1.75-11.0), an aneurysm diameter of more than 65 mm (HR, 2.19; 95% CI, 1.11-4.34), and an absence of coronary artery disease (HR, 1.26; 95% CI, 0.83-1.91), congestive heart failure (HR, 1.41; 95% CI, 1.03-1.92), and renal dysfunction (HR, 1.46; 95% CI, 1.04-2.05). In the patient cohort aged 80 and older, a lower hazard of mortality for EVAR versus open repair was observed for male patients or those with small aneurysms or certain comorbidities.

CONCLUSIONS

In a selected group of young patients with a substantial life expectancy, the long-term mortality is higher with EVAR compared with open repair for infrarenal AAAs. Long-term mortality with EVAR is similar in the middle cohort and lower in the elderly cohort compared with open repair.

摘要

目的

腹主动脉瘤(AAA)的血管内修复(EVAR)与开放修复的长期生存差异,特别是年龄对这些差异的影响仍然是一个争论的话题。因此,我们比较了不同年龄患者的 EVAR 和开放腹主动脉瘤修复的长期死亡率。

方法

这是一项回顾性队列研究,对血管质量倡议多国临床登记处(2003-2021 年)中接受择期 EVAR 或开放修复治疗的肾下 AAA 患者前瞻性收集的数据进行分析。主要结局是比较年龄小于 65 岁、65-79 岁和 80 岁及以上患者的 EVAR 和开放修复的长期全因死亡率。此外,我们还研究了在每个年龄组内,修复方式与 10 年死亡率风险之间的性别、动脉瘤直径和几种术前合并症之间的交互作用。为了考虑治疗的非随机分配,我们使用了倾向评分和逆概率加权 Cox 比例风险分析。

结果

我们在研究期间确定了 48074 名接受择期肾下腹主动脉瘤修复的患者(89%为 EVAR),包括 7940 名年龄小于 65 岁的患者、29555 名年龄在 65-79 岁之间的患者和 10579 名年龄在 80 岁或以上的患者。与开放修复相比,年龄小于 65 岁的患者中,EVAR 与更高的长期死亡率风险相关(风险比[HR],1.39;95%置信区间[CI],1.04-1.86;P=0.026)。在 65-79 岁的年龄组中,死亡率相似(HR,0.94;95%CI,0.79-1.10;P=0.43),而在 80 岁或以上的年龄组中,EVAR 与较低的死亡率风险相关(HR,0.63;95%CI,0.46-0.86;P=0.004)。在年龄小于 65 岁的患者中,与开放修复相比,EVAR 与女性(HR,4.40;95%CI,1.75-11.0)、动脉瘤直径大于 65mm(HR,2.19;95%CI,1.11-4.34)、无冠心病(HR,1.26;95%CI,0.83-1.91)、充血性心力衰竭(HR,1.41;95%CI,1.03-1.92)和肾功能不全(HR,1.46;95%CI,1.04-2.05)患者的死亡率风险更高。在 80 岁及以上的患者队列中,与开放修复相比,EVAR 的死亡率风险较低,见于男性患者或那些具有小动脉瘤或某些合并症的患者。

结论

在一组预期寿命较长的年轻患者中,与开放修复相比,EVAR 治疗肾下 AAA 的长期死亡率更高。在中年患者中,EVAR 的长期死亡率与开放修复相似,而在老年患者中则较低。

相似文献

1
Long-term age-stratified survival following endovascular and open abdominal aortic aneurysm repair.血管内和开放腹主动脉瘤修复后的长期年龄分层生存。
J Vasc Surg. 2022 Oct;76(4):899-907.e3. doi: 10.1016/j.jvs.2022.03.867. Epub 2022 Mar 31.
2
Late outcomes after endovascular and open repair of large abdominal aortic aneurysms.大型腹主动脉瘤血管内修复术和开放修复术后的远期疗效
J Vasc Surg. 2021 Oct;74(4):1152-1160. doi: 10.1016/j.jvs.2021.02.024. Epub 2021 Mar 6.
3
Midterm survival after endovascular repair of intact abdominal aortic aneurysms is improving over time.腔内修复完整腹主动脉瘤的中期生存率随着时间的推移而提高。
J Vasc Surg. 2020 Aug;72(2):556-565.e6. doi: 10.1016/j.jvs.2019.10.082. Epub 2020 Feb 21.
4
Contemporary outcomes of endovascular abdominal aortic aneurysm repair in patients deemed unfit for open surgical repair.血管内腹主动脉瘤修复术在被认为不适合开放手术修复的患者中的当代结果。
J Vasc Surg. 2021 May;73(5):1583-1592.e2. doi: 10.1016/j.jvs.2020.08.147. Epub 2020 Oct 6.
5
Fenestrated endovascular aneurysm repair is associated with lower perioperative morbidity and mortality compared with open repair for complex abdominal aortic aneurysms.与开放修复相比,开窗型血管内动脉瘤修复与复杂腹主动脉瘤围手术期较低的发病率和死亡率相关。
J Vasc Surg. 2019 Jun;69(6):1670-1678. doi: 10.1016/j.jvs.2018.08.192. Epub 2018 Dec 13.
6
Thoracic endovascular aortic repair of metachronous thoracic aortic aneurysms following prior infrarenal abdominal aortic aneurysm repair.胸主动脉腔内修复术治疗肾下型腹主动脉瘤修复术后同期性胸主动脉瘤
J Vasc Surg. 2023 Sep;78(3):614-623. doi: 10.1016/j.jvs.2023.05.037. Epub 2023 May 29.
7
Five-year survival following endovascular repair of ruptured abdominal aortic aneurysms is improving.血管内修复破裂的腹主动脉瘤后的 5 年生存率正在提高。
J Vasc Surg. 2020 Jul;72(1):105-113.e4. doi: 10.1016/j.jvs.2019.10.074. Epub 2020 Feb 21.
8
Surgery for small asymptomatic abdominal aortic aneurysms.无症状小腹部主动脉瘤的手术治疗。
Cochrane Database Syst Rev. 2020 Jul 1;7(7):CD001835. doi: 10.1002/14651858.CD001835.pub5.
9
Chronic kidney disease impacts outcomes after abdominal aortic aneurysm repair.慢性肾病会影响腹主动脉瘤修复术后的治疗效果。
J Vasc Surg. 2023 Feb;77(2):415-423.e1. doi: 10.1016/j.jvs.2022.09.003. Epub 2022 Sep 10.
10
Comparable perioperative mortality outcomes in younger patients undergoing elective open and endovascular abdominal aortic aneurysm repair.在接受择期开放和血管内腹主动脉瘤修复的年轻患者中,围手术期死亡率结果相当。
J Vasc Surg. 2018 May;67(5):1404-1409.e2. doi: 10.1016/j.jvs.2017.08.057. Epub 2017 Oct 31.

引用本文的文献

1
Endovascular repair for abdominal aortic aneurysms involving visceral arteries: Effectiveness and contributing factors.累及内脏动脉的腹主动脉瘤的血管腔内修复:有效性及影响因素
Heliyon. 2023 Nov 27;9(12):e22938. doi: 10.1016/j.heliyon.2023.e22938. eCollection 2023 Dec.